Micron Stock Is Up 311% Over the Last Year. Here's Why It's Still a Cheap Buy.

Micron reported Q2 FY2026 revenue of $23.9B, up 196% year-over-year and 75% sequentially, with gross margin expanding to 74% from 56% and higher free cash flow. Shares have risen 311% over the past year (48% YTD), yet the stock trades at ~20x trailing and just 7x forward earnings versus the Nasdaq-100 at ~35x and Nvidia at 21x. Strong AI-driven memory demand and materially improved margins support a bullish outlook, though downside remains if memory demand softens.

Analysis

The earnings beat is less important than the structural arbitrage Micron occupies between scarce AI memory (HBM/LPDDR) and relatively elastic DRAM/NAND capacity. Lead times for advanced packaging and EUV-dependent wafer fabs mean marginal supply response to AI demand is measured in quarters-to-years, giving pricing power early in a cycle and making near-term ASPs much more a function of constrained throughput than of durable end-market demand. Hyperscalers can and will front-load purchases to secure throughput, which amplifies short-run cyclicality: inventories tighten quickly and then often overcorrect once capex catches up.

Second-order beneficiaries include equipment and packaging vendors with long lead times and backlog (outsized cash flow coming through their order books next 12–24 months) and fabs that enjoy domestic policy shields—Micron is advantaged by CHIPS-style subsidies even as geopolitics raises the fixed-cost of operating in multiple jurisdictions. The real competitive threat is not demand but a capex arms race: if Samsung or SK Hynix accelerate EUV/HBM investments, the pricing tailwind could be cut short within 12–24 months and force a brutal ASP reset. Finally, investor positioning matters: crowded long flows into a liquidity-sensitive name can create steep drawdowns on any QoQ softness, so execution and hedging are as valuable as directional conviction.

Key Decisions for Investors

• Core long (MU) — initiate a 1–2% NAV position on a 3–6 week consolidation or on a pullback of 10–15%; hedge with 6–9 month 10% OTM puts sized to cover half the position. Time horizon 6–12 months; target asymmetric upside 30–60% if ASPs hold and FCF conversion remains strong; stop-loss if share price drops 20% from entry unaccompanied by fundamental deterioration.
• Options leverage — buy Jan 2027 LEAP calls (or equivalent 9–12 month calls) as a low-cost leveraged alternative; fund by selling near-term (90 day) calls for ~30% of premium to improve carry. This expresses a 12+ month thesis that constrained supply drives above-cycle margins while capping downside vs naked long.
• Pair trade to neutralize AI-beta — long MU vs short NVDA notional 1:0.35 (dollar-neutral) over 3–9 months. Rationale: preserves exposure to memory margin expansion while reducing valuation multiple contraction risk from crowded AI mega-cap long positions; unwind if NVDA underperforms tech by >15% or if MU inventory signals turn negative.
• Event/technical trigger — add to longs on confirmation of sustained wafer start discipline from competitors or on an announced multi-year CAPEX plan that materially accelerates HBM capacity; conversely, trim on signs of rapid industry capex ramp or easing lead times (ASML shipment cadence, packaging lines online) which would blunt pricing power within 12–24 months.